Guangdong Hybribio Biotech Co.Ltd(300639) : the hepatitis B virus nucleic acid quantitative detection kit (PCR fluorescent probe method) independently developed by the company has obtained the registration of three types of medical devices

Some investors asked questions on the investor interaction platform: the World Health Organization (who) said on Saturday that the number of cases of acute hepatitis in children with unknown etiology has increased. 12 countries have reported at least 169 cases of children and at least one death of children. Excuse me, secretary, does our company produce liver disease kits? thank you!

Guangdong Hybribio Biotech Co.Ltd(300639) ( Guangdong Hybribio Biotech Co.Ltd(300639) . SZ) said on the investor interaction platform on April 29 that the hepatitis B virus nucleic acid quantitative detection kit (PCR fluorescent probe method) independently developed by the company has obtained the registration certificate of three types of medical devices.

- Advertisment -